Skip to main content

Table. 2 clinical response and toxicity

From: The role of dosimetry and biological effects in metastatic castration–resistant prostate cancer (mCRPC) patients treated with 223Ra: first in human study

Pt.

# of 223Ra administrations

Patient response

(Imaging + marker + clinical status)

Toxicity

grade

Toxicity

type

PFS (months)

PFS event

OS

(months)

Cause of death

1

6

Responder

0

13

No Disease progression

13

No tumor related

2

6

No Responder

0

18

Disease progression

19

Disease progression

3

3

No Responder

3

Anemya

6

Disease progression

6

Disease progression

4

3

No Responder

3

Anemya

3

Disease progression

6

Disease progression

5

6

Responder

0

24

No Disease progression

24

Alive